These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8192895)

  • 1. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation.
    Gerrard JM; Robinson P; Narvey M; McNicol A
    Biochem Cell Biol; 1993; 71(9-10):432-9. PubMed ID: 8192895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid.
    McCrea JM; Robinson P; Gerrard JM
    Biochim Biophys Acta; 1985 Oct; 842(2-3):189-94. PubMed ID: 3931692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin.
    Gerrard JM; Robinson P
    Biochim Biophys Acta; 1989 Feb; 1001(3):282-5. PubMed ID: 2917152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of phospholipase C in platelet responses.
    Lapetina EG; Siess W
    Life Sci; 1983 Sep; 33(11):1011-8. PubMed ID: 6412009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
    Sato T; Nakao K; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid potentiates the thrombin-induced production of arachidonate metabolites in platelets.
    Lapetina EG; Billah MM; Cuatrecasas P
    J Biol Chem; 1981 Dec; 256(23):11984-7. PubMed ID: 6795196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of collagen-induced platelet activation by arachidonyl trifluoromethyl ketone.
    McNicol A; Nickolaychuk BR
    Biochem Pharmacol; 1995 Nov; 50(11):1795-802. PubMed ID: 8615857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid.
    Gerrard JM; Robinson P
    Biochim Biophys Acta; 1984 Oct; 795(3):487-92. PubMed ID: 6433985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonic acid stimulates the formation of 1,2-diacylglycerol and phosphatidic acid in human platelets. Degree of phospholipase C activation correlates with protein phosphorylation, platelet shape change, serotonin release, and aggregation.
    Siess W; Siegel FL; Lapetina EG
    J Biol Chem; 1983 Sep; 258(18):11236-42. PubMed ID: 6411729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation.
    Crouch MF; Lapetina EG
    Biochem Biophys Res Commun; 1988 May; 153(1):21-30. PubMed ID: 3132162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for cyclooxygenase products in the formation of phosphatidic acid in stimulated human platelets. Differential mechanisms of action of thrombin and collagen.
    Siess W; Cuatrecasas P; Lapetina EG
    J Biol Chem; 1983 Apr; 258(8):4683-6. PubMed ID: 6403533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second messenger function of phosphatidic acid in platelet activation.
    Kroll MH; Zavoico GB; Schafer AI
    J Cell Physiol; 1989 Jun; 139(3):558-64. PubMed ID: 2738101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
    Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
    Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of arachidonic acid in thrombin-stimulated human platelets.
    Mahadevappa VG; Sicilia F
    Biochem Cell Biol; 1990 Feb; 68(2):520-7. PubMed ID: 2111711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrageenan-induced activation of human platelets is independent of phospholipase A2 and of formation of thromboxanes.
    Vargaftig BB; Fouque F; Chignard M; Dumarey C
    J Pharm Pharmacol; 1980 Nov; 32(11):740-5. PubMed ID: 6110720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C.
    Simon MF; Chap H; Douste-Blazy L
    Biochim Biophys Acta; 1986 Feb; 875(2):157-64. PubMed ID: 3080024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct mechanisms of inhibition of platelets aggregation by acetylsalicylic acid.
    Ferri A; Calza R; Pellegrini A; Cattani L
    Biochem Mol Biol Int; 1994 Apr; 32(6):1101-7. PubMed ID: 8061627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of trifluoperazine on platelet activation.
    Ardlie NG; Boatwright C; Garrett J; McGuiness JA
    Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid.
    Watson SP; McConnell RT; Lapetina EG
    Biochem J; 1985 Nov; 232(1):61-6. PubMed ID: 3853461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.